8-24956493-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PM5PP5_Very_Strong
The NM_006158.5(NEFL):c.23C>T(p.Pro8Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P8Q) has been classified as Pathogenic.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NEFL
NM_006158.5 missense
NM_006158.5 missense
Scores
2
5
3
Clinical Significance
Conservation
PhyloP100: 2.76
Genes affected
NEFL (HGNC:7739): (neurofilament light chain) Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a region_of_interest Head (size 90) in uniprot entity NFL_HUMAN there are 16 pathogenic changes around while only 3 benign (84%) in NM_006158.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr8-24956493-G-T is described in Lovd as [Pathogenic].
PP5
Variant 8-24956493-G-A is Pathogenic according to our data. Variant chr8-24956493-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 66689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-24956493-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEFL | NM_006158.5 | c.23C>T | p.Pro8Leu | missense_variant | 1/4 | ENST00000610854.2 | NP_006149.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEFL | ENST00000610854.2 | c.23C>T | p.Pro8Leu | missense_variant | 1/4 | 1 | NM_006158.5 | ENSP00000482169 | P1 | |
ENST00000607735.2 | n.553G>A | non_coding_transcript_exon_variant | 1/1 | |||||||
NEFL | ENST00000615973.1 | n.229C>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1447836Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 718908
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1447836
Hom.:
Cov.:
36
AF XY:
AC XY:
0
AN XY:
718908
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.23C>T (p.P8L) alteration is located in exon 1 (coding exon 1) of the NEFL gene. This alteration results from a C to T substitution at nucleotide position 23, causing the proline (P) at amino acid position 8 to be replaced by a leucine (L). This variant is expected to be causative of autosomal dominant NEFL-related Charcot-Marie-Tooth; however, its clinical significance for autosomal recessive NEFL-related Charcot-Marie-Tooth disease is unclear. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been detected in the heterozygous state in multiple individuals with clinical features of autosomal dominant NEFL-related Charcot-Marie-Tooth disease (Kim, 2022; Jordanova, 2003; Abe, 2020). This amino acid position is not well conserved in available vertebrate species. Based on internal structural analysis, P8L is deleterious. The variant has an important role in aggregate formation and 14-3-3 protein association. In addition, there is another pathogenic variant (P8R) at the same position (Zhou, 2022; Miao, 2020; Perez-Olle, 2004). Functional studies show aberrant neurofilament formation in vitro compared to controls (Miao, 2020; Perez-Olle, 2004). The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as pathogenic. - |
Charcot-Marie-Tooth disease type 2E Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 29, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro8 amino acid residue in NEFL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12393795, 12566280, 17620486). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 66689). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 12566280, 19158810). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 8 of the NEFL protein (p.Pro8Leu). - |
not provided Other:1
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Benign
DEOGEN2
Uncertain
D;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D;D
MetaRNN
Uncertain
T;T;T
PrimateAI
Uncertain
T
Sift4G
Benign
T;.;T
Polyphen
D;.;.
Vest4
MVP
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at